First Header Logo Second Header Logo

Connection

Marshall Schwartz to Female

This is a "connection" page, showing publications Marshall Schwartz has written about Female.
Connection Strength

0.162
  1. Karmaker A, Costanzo CM, Schwartz MZ. Is OM-3 synergistic with GLP-2 in intestinal failure? J Surg Res. 2017 01; 207:7-12.
    View in: PubMed
    Score: 0.039
  2. Katz MS, Thatch KA, Schwartz MZ. Chronology of the effect of massive small bowel resection and hepatocyte growth factor (HGF) on intestinal adaptation. J Surg Res. 2011 Dec; 171(2):399-403.
    View in: PubMed
    Score: 0.027
  3. Katz MS, Thatch KA, Schwartz MZ. The effect of hepatocyte growth factor on gene transcription during intestinal adaptation. J Pediatr Surg. 2011 Feb; 46(2):357-65.
    View in: PubMed
    Score: 0.027
  4. Katz MS, Thatch KA, Schwartz MZ. Dose variation of hepatocyte growth factor and its effects on an animal model of TPN-induced liver injury. J Surg Res. 2010 Oct; 163(2):294-8.
    View in: PubMed
    Score: 0.025
  5. Weis VG, Deal AC, Mekkey G, Clouse C, Gaffley M, Whitaker E, Peeler CB, Weis JA, Schwartz MZ, Atala A. Human placental-derived stem cell therapy ameliorates experimental necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2021 04 01; 320(4):G658-G674.
    View in: PubMed
    Score: 0.013
  6. Walker SJ, Langefeld CD, Zimmerman K, Schwartz MZ, Krigsman A. A molecular biomarker for prediction of clinical outcome in children with ASD, constipation, and intestinal inflammation. Sci Rep. 2019 04 12; 9(1):5987.
    View in: PubMed
    Score: 0.012
  7. Sea S, Meckmongkol T, Moront ML, Timmapuri S, Prasad R, Schwartz MZ, Arthur LG. Vacuum-assisted closure: a novel method of managing surgical necrotizing enterocolitis. Eur J Pediatr Surg. 2015 Feb; 25(1):41-5.
    View in: PubMed
    Score: 0.009
  8. Thatch KA, Schwartz MZ, Yoo EY, Mendelson KG, Duke DS. Modulation of the inflammatory response and apoptosis using epidermal growth factor and hepatocyte growth factor in a liver injury model: a potential approach to the management and treatment of cholestatic liver disease. J Pediatr Surg. 2008 Dec; 43(12):2169-73.
    View in: PubMed
    Score: 0.006
  9. Arthur GL, Schwartz MZ, Kuenzler KA, Birbe R. Glucagonlike peptide-2 analogue: a possible new approach in the management of inflammatory bowel disease. J Pediatr Surg. 2004 Mar; 39(3):448-52; discussion 448-52.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.